US14040H1059 - Common Stock
2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue YoY % growth | 30.435B 6.70% | 34.25B 12.53% | 36.787B 7.41% | 38.663B 5.10% | |||||||
EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
EBIT YoY % growth | N/A | N/A | N/A | 18.85B | |||||||
Operating Margin | N/A | N/A | N/A | 48.75% | |||||||
EPS YoY % growth | 26.84 426.27% | 17.60 -34.43% | 12.52 -28.86% | 14.00 11.79% |
All data in USD
Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS Q2Q % growth | 3.34 44.51% | |||||||||||
Revenue Q2Q % growth | 9.437B 6.00% | |||||||||||
EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Q2Q % growth | 4.293B | N/A | N/A | N/A | N/A |
All data in USD
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q4 2023 Q2Q % growth | 2.24 -20.57% | 2.66 | -0.42 | -15.88% |
Q3 2023 Q2Q % growth | 4.45 5.95% | 3.29 | 1.16 | 35.43% |
Q2 2023 Q2Q % growth | 3.52 -29.03% | 3.26 | 0.26 | 8.05% |
Q1 2023 Q2Q % growth | 2.31 -58.90% | 3.96 | -1.65 | -41.62% |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q4 2023 Q2Q % growth | 9.506B 5.15% | 9.557B | -51M | -0.53% |
Q3 2023 Q2Q % growth | 9.366B 6.37% | 9.288B | 78M | 0.84% |
Q2 2023 Q2Q % growth | 9.012B 9.48% | 9.211B | -199M | -2.16% |
Q1 2023 Q2Q % growth | 8.903B 8.93% | 9.136B | -233M | -2.55% |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | 0.42% | -9.93% | -0.58% | 0.9% |
Revenue | 0.08% | -0.1% | 0.11% | 0.26% |